Verticals/Regulatory Intelligence

Regulatory Intelligence

What changed, what it means, and what your team must do before the deadline.

FDAEMACDSCOInspections
Meloxicam Injection: Uses, Benefits, and What You Should KnowArticle
Lead story

Meloxicam Injection: Uses, Benefits, and What You Should Know

A sprained ankle, an arthritis flare, a patient who can't swallow pills, here's when doctors reach for meloxicam injection instead.

Vaibhavi M. · Aug 03, 2026
Why Digital Batch Records Are Changing GMP Operations
Article

Why Digital Batch Records Are Changing GMP Operations

Paper batch records slow release and invite errors. Here's how digital batch records fix traceability, speed, and GMP data integrity.

Simantini Singh Deo · Jun 26, 2026
Beyond Smoke Studies: Why Airflow Visualisation Matters to GMP
Article

Beyond Smoke Studies: Why Airflow Visualisation Matters to GMP

Airflow visualisation is now central to GMP — dynamic studies, contamination control, training and CCS, all reshaped by Annex 1 (2022).

Vaibhavi M. · Jun 26, 2026
The Future Of Computerized Systems Validation (CSV)
Article

The Future Of Computerized Systems Validation (CSV)

CSV is being dismantled, not evolved. FDA's CSA shift, GAMP 5 Ed.2, and AI validation are rewriting pharma's rules in 2026.

Simantini Singh Deo · Jun 24, 2026
AI-Driven Quality by Design (QbD): Advancing Predictive, Data-Driven Pharmaceutical Formulation Development Using Artificial Neural Networks
Article

AI-Driven Quality by Design (QbD): Advancing Predictive, Data-Driven Pharmaceutical Formulation Development Using Artificial Neural Networks

Hybrid QbD-AI integrates neural networks with traditional DoE, achieving R² values above 0.998 in real formulation development studies.

Mr. Paritosh Singh · Jun 23, 2026
Can Regulators Trust AI-Generated Scientific Data?
Article

Can Regulators Trust AI-Generated Scientific Data?

FDA has 500+ AI submissions and rising. Hallucination rates hit 55% on niche topics. Here's the regulatory trust framework pharma must understand.

Simantini Singh Deo · Jun 19, 2026
Data Integrity in Pharma QC: Why ALCOA Is No Longer Enough
Article

Data Integrity in Pharma QC: Why ALCOA Is No Longer Enough

ALCOA is the baseline, not the ceiling. Here's why data integrity in pharma QC now demands culture, governance, cybersecurity, and AI oversight.

Dhanashree Akre · Jun 10, 2026
PATIENT CENTRICITY: DECODING ONCOLOGY & CHEMO TOXICITY MANAGEMENT
Article

PATIENT CENTRICITY: DECODING ONCOLOGY & CHEMO TOXICITY MANAGEMENT

CIPN, CINV, digital toxicity, logistic toxicity, decoded for pharma leaders building patient-centric oncology and chemo toxicity strategies.

Mrudula Kulkarni · Jun 04, 2026
Sanitation And Hygiene In Pharmaceutical Manufacturing: A Complete Guide To Schedule M 2023 Requirements
Article

Sanitation And Hygiene In Pharmaceutical Manufacturing: A Complete Guide To Schedule M 2023 Requirements

Schedule M 2023 makes sanitation a quality system, not housekeeping. Here's the complete five-pillar framework pharma manufacturers need.

Manish Bhatkar · Jun 04, 2026
EU Annex 22 Explained: What Pharma Manufacturers Need to Know About AI in GMP
Article

EU Annex 22 Explained: What Pharma Manufacturers Need to Know About AI in GMP

A practical breakdown of the European Commission's new guidance on Artificial Intelligence in pharmaceutical manufacturing

Vaibhavi M. · Jun 01, 2026
The QA Toolkit That Actually Matters: Risk Assessment And Quality Tools Explained
Article

The QA Toolkit That Actually Matters: Risk Assessment And Quality Tools Explained

Pharma QA toolkit: nine quality tools with case study, build steps, regulatory grounding. Risk assessment, CAPA integration, FDA GMP compliance.

Simantini Singh Deo · May 30, 2026
Key voices

The people shaping this field.

Simantini Singh Deo
FDA5 articles
Vaibhavi M.
4 articles
Mr. Paritosh Singh
1 article
Dhanashree Akre
EMA1 article
Mrudula Kulkarni
1 article
Manish Bhatkar
1 article